Safety, tolerability, and pharmacokinetics of edoxaban in end-stage renal disease subjects undergoing hemodialysis

被引：0
|
作者：
Parasrampuria, D. [1 ]
Matsushima, N. [2 ]
Chen, S. [1 ]
Wickremasingha, P. K. [3 ]
He, L. [1 ]
Dishy, V [1 ]
Brown, K. [1 ]
机构：
[1] Daiichi Sankyo Pharma Dev, Edison, NJ USA
[2] Daiichi Sankyo, Tokyo, Japan
[3] Certified Consultant Pharmacists Inc, Chatham, NJ USA
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：255 / 256
页数：2
相关论文
共 50 条
  • [1] Pharmacokinetics, safety, and tolerability of edoxaban in end-stage renal disease subjects undergoing haemodialysis
    Parasrampuria, Dolly A.
    Marbury, Thomas
    Matsushima, Nobuko
    Chen, Shuquan
    Wickremasingha, Prachi K.
    He, Ling
    Dishy, Victor
    Brown, Karen S.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2015, 113 (04) : 719 - 727
  • [2] Pharmacokinetics, safety, and tolerability of edoxaban in end-stage renal disease subjects undergoing haemodialysis (vol 113, pg 719, 2015)
    不详
    [J]. THROMBOSIS AND HAEMOSTASIS, 2017, 117 (04) : 821 - 821
  • [3] Venetoclax pharmacokinetics in subjects with end-stage renal disease undergoing hemodialysis
    Noorani, Behnam
    Menon, Rajeev
    Cen, Xin
    Marsh, Kennan
    Huang, Weize
    Gupta, Shelly
    Dobkowska, Edyta
    Marbury, Thomas
    Salem, Ahmed H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on hemodialysis
    Wang, Xiaoli
    Tirucherai, Giridhar
    Marbury, Thomas C.
    Wang, Jessie
    Chang, Ming
    Zhang, Donglu
    Song, Yan
    Pursley, Janice
    Boyd, Rebecca A.
    Frost, Charles
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (05): : 628 - 636
  • [5] THE PHARMACOKINETICS (PK) OF TOPIRAMATE (T) IN SUBJECTS WITH END-STAGE RENAL-DISEASE UNDERGOING HEMODIALYSIS
    GISCLON, LG
    CURTIN, CR
    SICA, DA
    GEHR, TWB
    SCHEIB, SS
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (02) : 196 - 196
  • [6] Safety and Tolerability of Remdesivir in Patients with End-stage Renal Disease on Maintenance Hemodialysis
    Shah, Maulin K.
    Parikh, Mital
    Prajapati, Dhavalkumar
    Kute, Vivek B.
    Bhende, Punam
    Prajapati, Abhishek
    Chhajwani, Sunil H.
    Yajnik, Krushan
    Ganjiwale, Jaishree
    Mannari, Jyoti G.
    Vaishnav, Bhalendu
    [J]. INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2022, 26 (05) : 617 - 623
  • [7] Pharmacokinetics, safety and tolerability of serelaxin in patients with severe renal impairment or end-stage renal disease
    Pang, Y. Yinuo
    Dahlke, M.
    Halabi, A.
    Canadi, J.
    Tsubouchi, C.
    Machineni, S.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 89 - 89
  • [8] Pharmacokinetics of topiramate in patients with renal impairment, end-stage renal disease undergoing hemodialysis, or hepatic impairment
    Manitpisitkul, Prasarn
    Curtin, Christopher R.
    Shalayda, Kevin
    Wang, Shean-Sheng
    Ford, Lisa
    Heald, Donald L.
    [J]. EPILEPSY RESEARCH, 2014, 108 (05) : 891 - 901
  • [9] PHARMACOKINETICS AND PHARMACODYNAMICS OF EVOGLIPTIN IN END-STAGE RENAL DISEASE PATIENTS ON HEMODIALYSIS
    Kim, B.
    Yu, K.
    Lee, S.
    Oh, J.
    Jang, I.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S67 - S67
  • [10] THE PHARMACOKINETICS OF AMINOGUANIDINE IN END-STAGE RENAL-DISEASE PATIENTS ON HEMODIALYSIS
    FOOTE, EF
    LOOK, ZM
    GILES, P
    KEANE, WF
    HALSTENSON, CE
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 25 (03) : 420 - 425
12345